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This study evaluates the proliferative eﬀects of danshen and its monomer extract, tanshinone IIA, on Schwann cell proliferation.
A piece of silicone rubber was guided across a 15-mm gap in the sciatic nerve of a rat. This nerve gap was then ﬁlled with diﬀerent
concentrations of danshen (0–100mg/mL). The results showed that danshen increased the expressions of uPA, cyclin D1, E and
ERK, JNK, and P38 MAP kinases via the FGF-2 signaling pathway in a dose-dependent manner. RSC96, Schwann cells were
also administered with danshen (0, 20, 40, 60, 80, and 100μg/mL) and tanshinone IIA (0, 2, 4, 6, 8, and 10μg/mL). In lower
concentrations,danshenand tanshinoneIIA exhibited anapparent eﬀect on Schwann cells. Similareﬀects were also demonstrated
in the FGF-2-uPA regulating cascade and cell cycle proliferative protein results. Schwann cell migration was elevated as well. We
usedMAPK-signalingchemicalinhibitorsandidentiﬁedtheproliferativeeﬀectsofdanshenandtanshinoneIIAasMAPK-signaling
dependent. The results from the in vitro systems indicate that danshen and tanshinone IIA can be used to induce Schwann cell
proliferation, and in vivo results potentially suggest that danshen and tanshinone IIA might enhance neuron regeneration.
1.Introduction
The central and peripheral nervous systems are composed
of neurons with diﬀerent anatomical structures and regen-
eration ability. Neuron injury elicits a cascade of physi-
ological responses that stimulate nerve cell regeneration.
In mammals, the central neurons do not have a myelin
sheath and therefore do not regenerate. Neurons in the
peripheralnervoussystemaresurroundedbyamyelin sheath
and can undergo regrowth [1]. The ability of neurons to
regenerate is due to intrinsic neuronal activities and the
presence of surrounding nonneuronal components, such as
Schwann cells. Schwann cells play a crucial role in endoge-
nous repair of peripheral nerves because of their ability to
dediﬀerentiate, migrate, proliferate, express growth promot-
ing factors, and myelinate regenerating axons. These cells
migrate from the periphery into the injury site, where they
apparently participate in endogenous repair processes [2]. If2 Evidence-Based Complementary and Alternative Medicine
regenerating axons gain a distal nerve, they elongate within
the endoneurial tubes, in association with the Schwann
cells and the basal lamina, constituting regenerative units
[3]. Schwann cells also produce some growth factors which
are crucial for peripheral nerve repair. Fibroblast growth
factor-2 (FGF-2) has a neruotrophic eﬀect on peripheral
nerve regeneration by maintaining cell survival [4]a n d
stimulatingcellproliferation[5].Interestingly, up-regulation
of FGF-2 in Schwann cells occurs only when the peripheral
nerves are injured [6]. Furthermore, urokinase plasminogen
activator(uPA)isinvolvedintissueregeneration.uPAcleaves
plasminogen to plasmin to promote extracellular matrix
(ECM) degradation for cell proliferation during the recovery
from injury [7]. Therefore, the ability of Schwann cells to
promote regeneration in peripheral neurons has led to an
increasing interest in using Schwann cells to study peripheral
nervous system repair. Enhancing the proliferative eﬀect of
Schwanncellsmightbeanotherpotentialapproachtoinduce
neuron regeneration.
Biomaterials combined with Chinese herbal medicine
have been applied in the study of nerve regeneration. For
example, a silicon rubber chamber ﬁlled with Schwann
cells bridged a 15-mm defect in rat sciatic nerves. Several
Chinese medicines have been identiﬁed to enhance neuron
regeneration. Therefore, targeting Schwann cells with herbal
medicines to induce neuron regrowth may be a possible
therapeutic approach for treating injured nerves. danshen
(Salvia miltiorrhiza) is a Chinese herb commonly used
in mainland China for the treatment of atherosclerosis-
related disorders such as cardiovascular and cerebrovascular
diseases.IntraditionalChinesemedicine,danshenisbelieved
to remove blood stasis and promote blood ﬂow, stimulate
menstrual bleeding, relieve pain and inﬂammation, and
reducestress[8].Danshenhasbeenshown tohaveanticancer
eﬀects [9] and inhibit oxysterol-induced endothelial cell
apoptosis [10]. Whether danshen has a nerve regenerating
eﬀectandgrowthenhancing eﬀectonSchwanncellsislargely
unknown. However, tanshinone IIA, a monomer extracted
from danshen, has been reported to have neuroprotective
eﬀects on neonatal hypoxia-ischemia brain damage [11]
and in transient focal cerebral ischemia [12]. Therefore,
we used an in vivo and in vitro system to compare the
eﬀects of danshen and tanshinone IIA on Schwann cell
proliferation neuron regeneration. In the animal model,
danshen at diﬀerent concentrations (0, 20, 40, 60, 80, and
100mg/mL) was injected into dissected rat sciatic nerves. In
the in vitro model, Schwann cells were treated with diﬀerent
concentrations of danshen (0, 20, 40, 60, 80, and 100μg/mL)
a n dt a n s h i n o n eI I A( 0 ,2 ,4 ,6 ,8 ,a n d1 0μg/mL).
2.Materialsand Methods
2.1. Danshen Extraction. Danshen (Ko Da pharmaceutical
company, Taoyuan, Taipei County, Taiwan) powder was
weighed and extracted using sterilized distillated deionized
water. The concentrations used in the animal model were
0, 20, 40, 60, 80, and 100mg/mL. The doses for the in vitro
model were 0, 20, 40, 60, 80, and 100μg/mL for Schwann cell
treatment. All of the solutions were stored at −20◦C. Pure
danshinone IIA (Jing-Ming chemical industry company,
Taichung, Taiwan) was dissolved in dimethyl sulfoxide
(DMSO). The following concentrations were prepared: 2, 4,
6, 8, and 10μg/mL.
2.2. Animal Model and Treatments. The surgery was per-
formed as described in a previous study [13]. Twenty-
four adult Sprague-Dawley rats (National Science Council)
weighing 220 ± 20gm, underwent silicone chamber place-
ment. Animals were equallydivided into six groups. Foreach
animal, the right legs received experimental treatment and
the left legs were used as the control. In the ﬁrst group, the
chambers were ﬁlled with saline only.
The chambers in groups 2∼6 were ﬁlled with diﬀerent
concentrations of danshen at 20, 40, 60, 80, and 100mg/mL,
respectively.
The chamber lumen volume was 25.5μL. Danshen was
injected through a precooled micropipette into the lumen
by passing the tip of the needle into the silicone rubber
chamber. Loading was performed as slowly as possible to
prevent the formation of air bubbles. The distal stump was
then secured at the other end of the chamber. Both the
proximal and distal stumps were secured to a depth of
1mm into the chamber, leaving a 15mm gap between the
stumps. The muscle layer was reapproximated using 4–0
chromic gut sutures, and the skin was closed with 2–0 silk
sutures. All animals were housed at 22◦C and 45% humidity
with a 12-hour light/dark cycle. They had free access to
rodent chow and water at libitum. After eight weeks, animals
were anesthetized by isoﬂurane (Abbott Laboratories Ltd.,
Queenborough, Kent, England), the nerves were reexposed
and the chambers across the 15mm gap were examined for
nerve regeneration. All animals were maintained in facilities
approved by the China Medical University for Accredited
Laboratory Animal Care, according to the regulations and
standards of the National Science Council of Health of the
Republic of China.
2.3.Cell CultureandTreatments. RSC96cellswerepurchased
from American Type Culture Collection (ATCC) and were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 4mM L-
glutamate, 1.5g/L sodium bicarbonate, and 1% Nonessential
amino acids (NEAA) in humidiﬁed atmosphere of 5% CO2
and 95% air. After 4-hour serum starvation, the cells were
treated with danshen and tanshinone IIA at concentrations
of 0, 20, 40, 60, 80, and 100μg / m La n d2 ,4 ,6 ,8a n d
10μg/mL, respectively. The incubation was continued for
another 16h, according to our preliminary test and then the
cells were harvested and extracted for analysis.
2.4. Inhibitors. RSC96 Schwann cells were treated with
several inhibitors, including SB203580 (p38 MAP kinase
inhibitor; Promega, Madison, WI, USA), U0126 (MEK1
and MEK2 inhibitor; Promega, Madison, WI, USA), and
SP600125 (JNK inhibitor; Promega, Madison, WI, USA).Evidence-Based Complementary and Alternative Medicine 3
The ﬁnal concentration of each inhibitor was 0.5μM,
according to our previous experiments.
2.5. Western Blotting. Sciatic nerve sections were extracted
f r o mt h em i d d l eo ft h er e g e n e r a t e dn e r v ei nt h ec h a m b e r .
Cultured RSC96 cells were scraped and washed. The proce-
dure was described in our previous study [5]. Proteins were
then separated by 12% gradient SDS-PAGE and transferred
to nitrocellulose membranes. Nonspeciﬁc protein binding
was stopped in blocking buﬀer (5% milk, 20mM Tris-
HCl, pH 7.6, 150mM NaCl, and 0.1% Tween 20) and
blotted with speciﬁc antibodies in the blocking buﬀer at 4◦C
overnight. For repeated blotting, nitrocellulose membranes
were stripped with Restore Western blot stripping buﬀer
(Pierce Biotechnology, Inc, Rockford, IL, USA) at room
temperature for 30min.
2.6. MTT Assay. Cell viability was estimated using a colori-
metric assay based on tetrazolium dye (MTT) conversion
into a blue formazan product. The procedure was described
in our previous study (Chen et al., 2007). After harvesting
andwashingtwicewithPBS,thecellswereculturedinphenol
red-free DMEM (1mL) with MTT (0.5mg/mL) at 37◦Cf o r
4h. The cells were incubated in iso-propenol (1mL) with
shaking for 10min. They were then aspirated and measured
spectrophotometerically at 570nm.
2.7. Wound Healing. Cells were initially seeded uniformly in
60-mm culture plates with an artiﬁcial “wound” carefully
created at 0h, using a sterile P-200 pipette tip to scratch on
the subconﬂuent cell monolayer to make a 1.0mm gap. After
24-hour exposure to diﬀerent concentrations of danshen
and tanshinone IIA, cells were calculated by counting the
number of cells that had advanced into the cell-free space
randomly selected from the initial wound border area.
Photographs were taken of the wounded regions using an
inverted Olympus microscope.
2.8. Zymograthphy. MMP-2 and MMP-9 activity was deter-
mined using gelatin zymography. RSC96 cells were treated
with diﬀerent concentrations of danshen and tanshinone
IIA which were already showed. Cell medium was collected
after incubation for 16 hours. Sample medium was elec-
trophoresed on an 8% polyacrylamide gel containing 0.1%
gelatin. After electrophoresis, the gel was washed for 30min
2 times in washing buﬀer (2.5% Triton X-100). The gel was
then incubated in incubation buﬀer (1% NaN3;2 MT r i s -
HCl, pH 8.0; 1M CaCl2)a t3 7 ◦C for 48 hours with shaking
and subsequentlystained with Coomassie blue.The presence
ofMMP-2 and MMP-9 gelatinolyticactivity wasidentiﬁed as
clear bands on a blue background after destaining.
2.9. Migration Assay. We used a Boyden chamber and
polyvinyl-pyrrolidone-free polycarbonate membranes with
8μM pores (Neuro Probes, Inc.) for the migration assay.
The bottom wells of the chamber were ﬁlled with 10% FBS
DMEM medium. The wells were covered with a membrane
sheet. The membranes were stained with Giemsa stain
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Figure 1: The regeneration of dissected sciatic nerves in the
chambersﬁlledwithdanshenandtanshinoneIIA.Thesciaticnerves
from the chamber in rats with surgery were taken and the FGF and
cell cycle signaling activities (a) and MAPK signaling activities (b)
were examined using western blotting analysis. The chambers in
the right legs were ﬁlled with various concentrations of danshen
and tanshinone IIA as indicated. The left represents the sciatic
nerves treated with saline from the left legs of each animal as an
experimental control. β-actin was used as a loading control.
(Sigma). Cells that migrated through the membrane were
counted using a counting grid ﬁtted into the eyepiece of a
phase contrast microscope.
2.10. Statistical Analysis. Statistical diﬀerences were assessed
using one way-ANOVA. P<. 05 was considered statistically
signiﬁcant. Data are expressed as the mean ± SEM.
3.Results
3.1. Proliferative Eﬀects of Danshen on Damaged Peripheral
Nerves in Animals. To investigate whether danshen can pro-
mote damaged nerveregeneration, various concentrations of
danshen were injected into silicon chambers connecting the
distal and proximal stumps of sciatic nerves. Danshen acti-
vated the FGF-signaling pathway as evidenced by increased
levelsofFGF-2anduPA.The cyclinproteins,D1,E,werealso
increased (Figure 1(a)). To identify the role of MAPK sig-
naling in danshen-induced nervecellproliferation, we exam-
ined the MAPK signaling activities in regenerated nerves and
found that the levels of phosphorylated ERK, JNK, and P38
were increased (Figure 1(b)). These observations indicate
that danshen might promote nerve regenerative markers,
such as FGF-signaling, cell cycle activity, and MAPKs, ERK-,
JNK- and P38-signaling pathways.
3.2. Dose-Dependent Proliferation of RSC Cells by Danshen
and Tanshinone IIA In Vitro. At 16h of culture, MTT
assay revealed that danshen (20∼100μg/mL) and tanshinone4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Proliferative eﬀects of danshen and tanshinoneIIA on RSC96 cell viability and migration.RSC cells were incubated with diﬀerent
doses of danshen and tanshinone IIA as indicated. Cell viability was measured using MTT assay (a), and western blotting analysis (b); cell
migration was measured using wound healing analysis (c). The procedures are described in the materials and methods section. The wound
healing data were quantiﬁed by measuring the number of cells that had advanced into the cell-free space (d). Data are shown as the mean of
three independent experiments ± SE. ∗, ∗∗,a n d∗∗∗ denote signiﬁcant diﬀerences between experimental and control values, with P<. 05,
P<. 01, and P<. 001, respectively. α-Tubulin was used as a loading control. PCNA: proliferating cell nuclear antigen.
IIA (2∼10μg/mL) had a signiﬁcant proliferative eﬀect on
RSC cells in a dose-dependent manner using MTT assay
for 24h culture. However, cellular viability was no eﬀect
with high concentrations of danshen (Figure 2(a)). The
level of PCNA (proliferation cell nuclear antigen) protein
expression in RSC cells also increased after treatment with
danshen and tanshinone IIA (Figure 2(b)). Therefore, we
performed an in vitro wound healing assay to evaluate the
migration potential of Schwann cells treated with various
concentrations of danshen and tanshinone IIA and found
that the cell migration was promoted by danshen and
tanshinone IIA treatment (Figures 2(c) and 2(d)). These
observations provide that danshen and tanshinone IIA not
only induce Schwann cell proliferation but also migration,
thereby enhancing nerve regeneration.
3.3. Proliferative and Migrative Eﬀects of Danshen and Tan-
shinone IIA on Schwann Cells. We evaluated the proliferative
eﬀect of danshen and tanshinone IIA on the regenerative
ability of Schwann cells, which play an important role in
nerve regeneration. As shown in Figure 3(a),r e p r e s e n t i n g
the protein level results, administration of danshen and
tanshinone IIA increased the level of FGF-2, MMP 9, and
uPA but decreased the level of PAI-1. The two compounds
also promoted cell cycle activity by increasing the levels ofEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Exaiminationofcell cycle signaling(a),activated FGF signaling(b, c),and Schwann cell migration ofdanshen and tanshinoneIIA
on RSC. RSC cells were incubated with diﬀerent doses of danshen and tanshinone IIA as indicated for 16hrs. Cells were then lysed. Protein
was extracted and analyzed using western blotting. α-tubulin was used as a loading control. (c) Matrix metalloprotease-9 and -2 enzyme
activity was examined using zymography. (d) The Schwann cell migrationwas examined using the Boyden chamber system. The number of
cells that had migrated were quantitated using the mean value of 10 microscopic ﬁelds in every condition. ∗, ∗∗,a n d∗∗∗ denote signiﬁcant
diﬀerences between experimental and control values, with P<. 05, P<. 01, and P<. 001.
cyclin proteins, D1, E, and A (Figure 3(b)). Zymography
revealedMMP 9enzyme activity increased after danshen and
tanshinone IIA treatment (Figure 3(c)). Using the Boyden
chamber to observe Schwann cell migration, we found that
cell migration increased after danshen and tanshinone IIA
treatment (Figure 3(d)). These results provide evidence
that danshen and tanshinone IIA have proliferative and
migrative eﬀects on Schwann cells. The maximum danshen
and tanshinone IIA eﬀects were observed at concentrations
of 20–60μg/mL and 2–8μg/mL, respectively. Some of the
eﬀects reversed back to the basal level at doses of 80,
and 100μg/mL in Danshen 10μg/mL in Tanshinone IIA,6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: The proliferative eﬀect of danshen and tanshinone IIA on RSC96 cell viability has ERK-, JNK- and P38-signaling dependent.
The RSC96 cells were treated with various doses of danshen and tanshinone IIA. The treatments and procedures are the same as those
described for Figure 3. The MAPK-signaling activities were measured using western blotting (a). The RSC96 cells were treated with danshen
and tanshinone IIA at concentrations of 40μg/mL and 4μg/mL, respectively, and MAPK signaling inhibitors as indicated. Cell viability was
examined using MTT assay (b); the cell proliferation was analyzed using western blot analysis of PCNA (c). α-tubulin was used as a loading
control.U0126,SB203508,andSP600125areinhibitors ofMEK,P38,andJNK,respectively. ## and ### denote signiﬁcantdiﬀerences between
experimental and control values with P<. 01, and P<. 001. ∗, ∗∗,a n d∗∗∗ denote signiﬁcant diﬀerences between danshen and tanshinone
IIA values with P<. 05, P<. 01, and P<. 001.
indicating thatdanshen andtanshinone IIA are toxic atthose
concentrations.
3.4. RSC Cell Proliferation Enhanced by Danshen and
Tanshinone IIA Is MAPK Signaling-Dependent In Vitro.
Intracellular MAPK signaling components, ERK1/2,JNK1/2,
P38, and their phosphorylations were measured by western
blotting. Our data showed, danshen and tanshinone IIA
treatment increased the level of ERK1/2, JNK1/2 and P38
phosphorylation. Treatment also increased the total protein
levels of ERK1/2, JNK1/2, but did not increase that of P38.
However, danshen and tanshinone IIA at concentrations of
100μg/mL and 10μg/mL, respectively, reduced the level of
phosphorylation and total protein levels of ERK1/2, JNK1/2,
and P38 (Figure 4(a)). To further investigate the roles that
MAPKs play in danshen and tanshinone IIA-induced cell
proliferation, RSC cells were pretreated with pharmacolog-
ical inhibitors of individual MAPKs, followed by incubation
with danshen and tanshinone IIA at concentrations of
40μg/mL and 4μg/mL, respectively, for 24h. All inhibitors,
U0126 (a potent inhibitor of MEK), SP600125 (a potent
inhibitor of JNK), and SB203580 (a potent inhibitor of P38).
MTT assay revealed that all three MAPK inhibitors signif-
icantly decreased the level of danshen and tanshinone IIA-
induced cell viability (Figure 4(b)). PCNA protein levels in
danshen and tanshinone IIA-treated RSC cells that had been
pretreatment with individual inhibitors were also examined.
We found that the PCNA levels were signiﬁcantly reduced
after pretreatment with inhibitors of ERK1/2, JNK1/2, and
P38 (Figure 4(c)). These results indicate that signaling of
MAPK signaling pathway is involved in the proliferative
eﬀect of danshen and tanshinone IIA on Schwann cells.
4.Discussion
The combination of herbal medicine and biomedical mate-
rial science to promote functional recovery of damagedEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Schematic model of the proliferative eﬀects and nerve
regeneration involving MAPK-signaling pathways in Schwann cells
and peripheral neurons exposed to danshen and tanshinone IIA.
StimulationofneuronsandSchwanncells withdanshenandtanshi-
none IIA activates FGF-2 signaling, leading to the up-regulation of
uPA,down-regulatingofPAI-1,whichinturnactivatedthecellcycle
by increasing cyclin protein (a), (d), and (e), thereby enhancing
proliferation and regeneration.
peripheral neurons has received much attention in recent
years. Based on our previous study [13, 14], using a silicone
rubber chamber ﬁlled with a mixture of herbal product
and Schwann cells for bridging a 15-mm gap for rat
sciatic nerves is a good model to evaluate the capacity for
regenerating neurons. Schwann cells produce and release
adhesion molecules and trophic factors which are vital
requirements for successful nerve regeneration following
injury [15]. Danshen (Salvia miltiorrhiza) is a commonly
used Chinese herb in mainland China for the treatment
of atherosclerosis-related disorders such as cardiovascular
and cerebrovascular diseases. It has been reported to have
anticancereﬀectandtoinhibitoxysterol-inducedendothelial
cell apoptosis.
However, whether danshen can enhance the growth
of peripheral neurons and Schwann cells is unknown.
tanshinone IIA, a monomer extracted from danshen, has
beenreportedtohaveneuroprotectiveeﬀectsondamagearea
of the brain. In the present study, treatments of diﬀerent
concentrations of danshen (0, 20, 40, 60, 80, 100mg/mL)
had a proliferative eﬀect on the sciatic nerve regeneration
in rats. Consistently, RSC96 Schwann cells treated with
concentrations of danshen (0, 20, 40, 60, 80, and 100μg/mL)
a n dt a n s h i n o n eI I A( 0 ,2 ,4 ,6 ,8 ,a n d1 0μg/mL) had a dose-
dependent proliferative eﬀects. These proliferative eﬀects of
danshen and tanshinone IIA were also observedin theresults
of FGF2-uPA regulating cascade, cell cycle proliferative
proteins, and cyclins. In addition, zymography showed that
theenzyme activity ofextracellular matrix regulating protein
(MMP 9) and the migration of Schwann cells were increased
after danshen and tanshinone IIA treatment. Furthermore,
using chemical inhibitors, theproliferative eﬀectsofdanshen
and tanshinone IIA on RSC cells were found to be P38-,
ERK-, JNK-, and MAPK-signaling dependent. These results
provide evidence that danshen and tanshinone IIA promote
the proliferation of Schwann cells and might enhance the
reconstructing of peripheral nerve defects (Figure 5).
Fibroblast growth factor (FGF), a 16–18kDa protein and
potent trophic factor for a number of tissues, can promotes
survival and stimulates proliferation of neural cells and
Schwann cells [16–18]. FGF also can promote the extension
of early regenerating axons by directly inﬂuencing the
axons unaccompanied by Schwann cells [19]. This evidence
suggests that there is a possible connection between FGF
expressionand injured-neuronrepair. Inthisstudy,dissected
sciatic nerves and Schwann cells that had been exposed to
danshen showed increased levels of FGF-2. Tanshinone IIA
also increased the protein expression of FGF-2, indicating
that these two compounds have a proliferative eﬀect on
neuronal cells.
Degradation of the extracellular matrix (ECM) is asso-
ciated with the development of tumor metastasis and tissue
growth. One of the key regulators of this process is the serine
protease, urokinase plaminogen activator (uPA), which
converts the zymogen plasminogen into active plasmin. It
is known to act on a wide variety of components of the
ECM [20]. Consistent with its role in metastasis, high uPA
levels are present in cancers with poor prognosis. The cell
proliferation and diﬀerentiation process is also an event
involving uPA catalytic ECM degradation that increases cell
migration by activating MMP 9 [21]. FGF is one of the
mediators of uPA activity [22–24]. In contrast, PAI-1 is
thought to be the major inhibitor of uPA [20]. Our results
show that danshen and tanshinone IIA increased the level of
uPA and decreased the level of PAI-1 in a dose-dependent
manner.
Mitogen-activated protein kinases (MAPKs) mediate
critical signaling pathways that involved in cell proliferation
and diﬀerentiation [25]. There are three subfamilies of
MAPKs: extracellular signal-regulated kinases (ERK), NH2-
terminal kinases (JNK), and P38 kinase. They are important
players in regulating a variety of signaling pathways during
organism development, cell cycle regulation, cell prolifera-
tion and diﬀerentiation, and other cellular and physiological
processes [21, 26]. In our study, the results from western
blotting analysis and MTT-with inhibitors assay (Figure 1(b)
and Figures 4(a)–4(c))r e v e a l e dt h a tJ N K ,E R Ka n dP 3 8a r e
involved in the proliferative eﬀect of danshen on neuron
regeneration both in vivo and in vitro. Tanshinone IIA had
a similar eﬀect on Rsc 96 cells. It is also reported that
the highly expressed uPA in the epidermal of damaged
tissue is regulated by FGF-2 which aﬀects MAPK kinase
kinase (MEKK-1)andMEKK-1’sdownstream NH2-terminal
kinases (JNK), and extracellular signal-regulated (ERK) for
controlling uPA activity [22–24]. Therefore, danshen and
tanshinone IIA-enhanced uPA activity using FGF2 might
mediate through the JNK and ERK signaling pathways.
Due to the requirement in appropriate basal lamina
scaﬀolds for regenerating axons to attach and a suﬃcient
nutritional supply, the Schwann cell plays an important role8 Evidence-Based Complementary and Alternative Medicine
for axon regeneration. The results of Fujimoto’s study [19]
demonstrated that the FGF receptor was expressed on the
plasma membrane of regenerating axons and that exoge-
nously applied FGF bound to the basal lamina, indicating
that the binding of FGF and to its receptor facilitates axon
regeneration. During regeneration, Schwann cells supplied
the sources of exogenous FGF and the basal lamina to
promote nerve regeneration. In our results, danshen and
tanshinone IIA-treated Schwann cells demonstrated dose-
dependently increased growth rate (Figures 2(a)–2(c)), pro-
tein levels of FGF-2, its downstream JNK, ERK and even
P38 signaling, and uPA activity with inhibited PAI-1 and
the activation of cyclin D, E and B (Figures 3(a)-3(b)
and Figures 4(a)–4(c)) at lower doses of two components,
indicating that danshen and tanshinone IIA suﬃciently
enhance the potential of Schwann cell proliferation for
neuron regeneration.
Danshen is a commonly used Chinese medicine. In addi-
tion to the discovered health-promoting eﬀects mentioned
above, the ﬁndings of this study provide another novel
danshen neuron regeneration function. However, high doses
of danshen and tanshinone IIA suppressed nerve regen-
eration in Rsc96 Schwann cells, indicating that excessively
high concentrations of danshen and tanshinone IIA in the
tube or medium may have an adverse eﬀect. Therefore, an
appropriate dosage of danshen and tanshinone IIA should
be carefully selected for enhancing neuron regeneration.
Moreover, further studies are needed to investigate
whether the combination of Schwann cells or otherbiomate-
rials with danshen and tanshinone IIA at appropriate dosage
canact additivelyonthe regenerating neuronin thechamber
transected into the dissected sciatic nerve in rats.
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